当前位置:
X-MOL 学术
›
Hepatology
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Postvaccination COVID-19 infection is associated with reduced mortality in patients with cirrhosis
Hepatology ( IF 12.9 ) Pub Date : 2022-01-12 , DOI: 10.1002/hep.32337 Binu V John 1, 2 , Yangyang Deng 3 , Kaley B Schwartz 1 , Tamar H Taddei 4, 5 , David E Kaplan 6, 7 , Paul Martin 1, 2 , Hann-Hsiang Chao 8 , Bassam Dahman 3
Hepatology ( IF 12.9 ) Pub Date : 2022-01-12 , DOI: 10.1002/hep.32337 Binu V John 1, 2 , Yangyang Deng 3 , Kaley B Schwartz 1 , Tamar H Taddei 4, 5 , David E Kaplan 6, 7 , Paul Martin 1, 2 , Hann-Hsiang Chao 8 , Bassam Dahman 3
Affiliation
Patients develop breakthrough COVID-19 infection despite vaccination. The aim of this study was to identify outcomes in patients with cirrhosis who developed postvaccination COVID-19.
中文翻译:
疫苗接种后 COVID-19 感染与肝硬化患者死亡率降低有关
尽管接种疫苗,患者仍会发生突破性 COVID-19 感染。本研究的目的是确定接种疫苗后发生 COVID-19 的肝硬化患者的结局。
更新日期:2022-01-12
中文翻译:
疫苗接种后 COVID-19 感染与肝硬化患者死亡率降低有关
尽管接种疫苗,患者仍会发生突破性 COVID-19 感染。本研究的目的是确定接种疫苗后发生 COVID-19 的肝硬化患者的结局。